Search

Displaying results 5981 - 5990 of 10000 in total
  1. Drug

    Phoenix dactylifera pollen

    go.drugbank.com/drugs/DB10950
    Approved

    Phoenix dactylifera pollen is mainly used in allergenic testing.

  2. Drug

    Phalaris minor pollen

    go.drugbank.com/drugs/DB10963
    Approved

    Phalaris minor pollen is mainly used in allergenic testing.

  3. Drug

    Ulmus parvifolia pollen

    go.drugbank.com/drugs/DB11005
    Approved

    Ulmus parvifolia pollen is mainly used in allergenic testing.

  4. Drug

    Schinus terebinthifolia pollen

    go.drugbank.com/drugs/DB21762
    Approved

    Schinus terebinthifolia pollen is mainly used in allergenic testing.

  5. Drug

    Serabelisib

    go.drugbank.com/drugs/DB14935
    Investigational

    of TAK-117 (MLN1117) in Healthy Participants). … Serabelisib is under investigation in clinical trial NCT02625259 (A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics

  6. Drug

    Saredutant

    go.drugbank.com/drugs/DB06660
    Investigational

    Saredutant (SR 48968) is a neurokinin-2 antagonist drug being developed as an antidepressant and anxiolytic by Sanofi-Aventis.

  7. Drug

    Etazolate

    go.drugbank.com/drugs/DB05881
    Investigational

    EHT 0202 is developed to treat neurodegenerative disorders by ExonHit Therapeutics.

  8. Drug

    Refametinib

    go.drugbank.com/drugs/DB06309
    Investigational

  9. Drug

    MD-0727

    go.drugbank.com/drugs/DB05948
    Investigational

    MD-0727 is a novel, potent cholesterol absorption inhibitor (CAI) under investigation for the treatment of hypercholesterolemia (high cholesterol.

  10. Drug

    MLN2704

    go.drugbank.com/drugs/DB06513
    Investigational

    A Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.